COVID: South Africa to resume vaccine rollout with J&J jab

Decision comes after Johnson & Johnson vaccine was temporary suspended for a possible link between jab and blood clots.

South Africa has announced it will resume its vaccination rollout with the Johnson & Johnson vaccine following a temporary suspension for a possible link between the jab and blood clots. The one-shot vaccine will be administered again starting from Wednesday. It had been put on hold after six people in the United States developed blood clots after inoculation prompting the US government to briefly suspend its use.